Reference
Health Canada. ZYDELIG (idelalisib) - Increased Risk of Fatal and Serious Infections. Internet Document : 3 May 2016. Available from: URL: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58118a-eng.php
Rights and permissions
About this article
Cite this article
Idelalisib associated with increased risk of serious infections. Reactions Weekly 1602, 3 (2016). https://doi.org/10.1007/s40278-016-17547-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-17547-3